公开(公告)号：US20160193234A1

公开(公告)日：2016-07-07

申请号：US14774220

申请日：2014-03-06

Applicant: CATHOLIC UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION

Inventor： Choun-Ki JOO ,  Jun-Sub CHOI

IPC: A61K31/655 ,  A61K47/48 ,  A61K9/08 ,  A61K47/36 ,  A61K9/00

CPC classification number: A61K47/48215 ,  A61K9/0048 ,  A61K9/08 ,  A61K31/635 ,  A61K47/10 ,  A61K47/36 ,  A61K47/60

Abstract: The present invention relates to a composition for treating an ocular inflammatory disease, comprising hydrophilic sulfasalazine and hyaluronic acid, and a preparation method therefor. Furthermore, the present invention relates to a method for treating an ocular inflammatory disease, which comprises administering, to an individual, a therapeutically effective amount of hydrophilic sulfasalazine and hyaluronic acid.

Abstract translation: 本发明涉及用于治疗眼炎症的组合物，其包含亲水性柳氮磺吡啶和透明质酸及其制备方法。 此外，本发明涉及治疗眼部炎性疾病的方法，其包括向个体施用治疗有效量的亲水性柳氮磺吡啶和透明质酸。

公开(公告)号：US20180221343A1

公开(公告)日：2018-08-09

申请号：US15941856

申请日：2018-03-30

Applicant: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY ,  CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION

Inventor： Kyu-Yang YI ,  Sung-Eun YOO ,  Nack-Jeong KIM ,  Jee-Hee SUH ,  Choun-Ki JOO ,  Jun-Sub CHOI ,  Jae-Sik YANG ,  Geun-Hyeog LEE ,  Yun-Seok CHO ,  Jin-Ha PARK ,  Hye-Sung LEE

IPC: A61K31/4178 ,  A61P27/02 ,  A61K9/00 ,  A61K9/08

CPC classification number: A61K31/4178 ,  A61K9/0048 ,  A61K9/08 ,  A61K9/10 ,  A61K47/10 ,  A61K47/32 ,  A61P27/02

Abstract: The present invention provides a pharmaceutical composition for preventing or treating macular degeneration, which comprises benzopyran derivatives substituted with secondary amines including imidazole or pharmaceutically acceptable salts thereof as an active ingredient. The pharmaceutical composition of the present invention may be used in the form of eye drops.